GelPOINT® Path-Assisted Endoscopic Removal of Colon and Rectal Polyps: A Feasibility and Safety Study
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Baylor College of Medicine
- Study ID
- NCT07723937
- Status
- Recruiting
Conditions
- Adenoma Colon Polyp
- Polyp Colorectal
- Rectal Adenoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This prospective, single-center, observational feasibility and safety study will evaluate the use of the GelPOINT® Path transanal access platform during endoscopic submucosal dissection (ESD) for the removal of colorectal polyps. The GelPOINT® Path system is designed to improve access, maintain stable insufflation, and enhance visualization during advanced endoscopic procedures. The study will enroll adult patients undergoing ESD for eligible colorectal lesions. The primary objective is to evaluate the technical feasibility, procedural performance, and safety of GelPOINT® Path-assisted ESD. Procedural outcomes, including procedure speed, technical success, resection outcomes, and procedure-related adverse events, will be collected prospectively. Participants will receive standard clinical care and will be followed for approximately 4 weeks after the procedure to assess delayed adverse events.
Key Dates
- First listed
- Jul 23, 2026
- Start date
- May 19, 2026
- Status verified
- Apr 2026
- Primary completion
- Mar 25, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: GelPOINT® Path-Assisted ESDAdult participants undergoing endoscopic submucosal dissection (ESD) for eligible colorectal polyps using the GelPOINT® Path transanal access platform as part of standard clinical care. The study will prospectively evaluate the feasibility, technical performance, and safety of GelPOINT® Path-assisted ESD, including procedural outcomes and procedure-related adverse events.
Primary Outcome Measure
Procedure Speed [ Time Frame: During the index procedure ]
Central Contacts
- Tara Keihanian, MD631-800-4142
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Baylor College of Medicine | Houston | Texas | 77030 | Mohamed Othman, MD (SUB_INVESTIGATOR) Fares Ayoub, MD (SUB_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft CoagulationRecruiting · AdventHealth · Orlando, Florida